1. Home
  2. ICU vs MNDO Comparison

ICU vs MNDO Comparison

Compare ICU & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • MNDO
  • Stock Information
  • Founded
  • ICU 2018
  • MNDO 1995
  • Country
  • ICU United States
  • MNDO Israel
  • Employees
  • ICU N/A
  • MNDO N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • MNDO EDP Services
  • Sector
  • ICU Health Care
  • MNDO Technology
  • Exchange
  • ICU Nasdaq
  • MNDO Nasdaq
  • Market Cap
  • ICU 25.6M
  • MNDO 24.2M
  • IPO Year
  • ICU N/A
  • MNDO 2000
  • Fundamental
  • Price
  • ICU $0.87
  • MNDO $1.19
  • Analyst Decision
  • ICU
  • MNDO
  • Analyst Count
  • ICU 0
  • MNDO 0
  • Target Price
  • ICU N/A
  • MNDO N/A
  • AVG Volume (30 Days)
  • ICU 1.1M
  • MNDO 33.1K
  • Earning Date
  • ICU 11-12-2025
  • MNDO 11-04-2025
  • Dividend Yield
  • ICU N/A
  • MNDO 18.49%
  • EPS Growth
  • ICU N/A
  • MNDO N/A
  • EPS
  • ICU N/A
  • MNDO 0.15
  • Revenue
  • ICU $766,000.00
  • MNDO $20,155,000.00
  • Revenue This Year
  • ICU $894.81
  • MNDO N/A
  • Revenue Next Year
  • ICU $71.78
  • MNDO N/A
  • P/E Ratio
  • ICU N/A
  • MNDO $7.93
  • Revenue Growth
  • ICU N/A
  • MNDO N/A
  • 52 Week Low
  • ICU $0.31
  • MNDO $1.02
  • 52 Week High
  • ICU $5.34
  • MNDO $2.13
  • Technical
  • Relative Strength Index (RSI)
  • ICU 54.67
  • MNDO 44.03
  • Support Level
  • ICU $0.83
  • MNDO $1.16
  • Resistance Level
  • ICU $0.91
  • MNDO $1.22
  • Average True Range (ATR)
  • ICU 0.07
  • MNDO 0.03
  • MACD
  • ICU -0.00
  • MNDO 0.01
  • Stochastic Oscillator
  • ICU 54.45
  • MNDO 57.14

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

Share on Social Networks: